Anti-PD-L1 from Rabbit (HL1041) - unconj., IgG, Unconjugated, Monoclonal
Catalog Number:
DNA-IHC-184010
- Images (2)
Article Name: | Anti-PD-L1 from Rabbit (HL1041) - unconj., IgG, Unconjugated, Monoclonal |
Biozol Catalog Number: | DNA-IHC-184010 |
Supplier Catalog Number: | IHC-184010 |
Alternative Catalog Number: | DNA-IHC-184010 |
Manufacturer: | dianova |
Host: | Rabbit |
Category: | Antikörper |
Application: | IHC-P, IHC-F |
Species Reactivity: | Human |
Immunogen: | Carrier-protein conjugated synthetic peptide encompassing a sequence within the C-terminus region of human PD-L1. The exact sequence is proprietary. |
Conjugation: | Unconjugated |
Alternative Names: | CD274 molecule , B7-H , B7H1 , PD-L1 , PDCD1L1 , PDCD1LG1 , PDL1 |
Anti-PD-L1 from Rabbit (HL1041) - unconj., IgG, Unconjugated, Monoclonal |
This antibody is specific for PD-L1 protein, ligand of immune checkpoint receptor PD-1. Cancer cells and the cells of the surrounding microenvironment have been shown to upregulate the expression of components to suppress the antitumor immune response by generating coinhibitory signals. PD-1 and CTLA-4 emerged as the most successful immune targets for anticancer therapies. The PD-1/PD-L1 and CTLA-4 axis also has become a focus of SARS-CoV-2 research, as PD-L1 and CTLA-4 mediated T-cell dysfunction and exhaustion is observed in symptomatic COVID-19 patients. This PD-L1 antibody shows no cross-reaction with SARS-CoV or MERS-CoV spike proteins.
Positive Control: Placenta, Tonsil |
Clonality: | Monoclonal |
Concentration: | 1 mg/ml (Please refer to the vial label for the specific concentration.) |
Clone Designation: | HL1041 |
Molecular Weight: | 33 |
Isotype: | IgG |
NCBI: | 29126 |
UniProt: | Q9NZQ7 |
Buffer: | PBS |
Purity: | Affinity purified by Protein A. |
Target: | Carrier-protein conjugated synthetic peptide encompassing a sequence within the C-terminus region of human PD-L1. The exact sequence is proprietary. |